Want to join the conversation?
For FY16, $EMR's underlying sales is expected to be down 5-6% excluding negative currency translation and an impact from completed divestitures of approx. 2% each. Reported sales is expected to be down 9-10%. Reported EPS is now expected to be between $2.37-2.55, while adjusted EPS is revised to $2.37-2.55 from $3.05-3.25.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.